Quebec launches AReNA to become a world leader in RNA therapies
San Diego, California – June 3, 2024 – CQDM in collaboration with ARN Québec, Axelys and Montréal InVivo is proud to present AReNA, the new ARN Center of Québec. Unveiled during the BIO conference in San Diego, in the presence of the Minister for the Economy, Minister responsible for the Fight against Racism and Minister responsible for the Laval region, Mr. Christopher Skeete, this initiative brings together the main players in science of life and aims to propel Quebec to the top of innovation in the field of RNA therapies.
AReNA promises to promote all stakeholders in Quebec's RNA therapy sector on a provincial, national and international scale. AReNA is one of the five key initiatives of the mobilizing project on RNA therapies announced on April 30 by the government of Quebec.
AReNA will set up a website which will offer an exhaustive portrait of the RNA therapy sector in Quebec. The AReNa site will become a powerful communication and reference tool for all stakeholders in the RNA field, both in Quebec and internationally. We invite you to discover it: arenapole.ca .
AReNA will also offer a program of events aimed at promoting partnerships between industry and the academic network, both locally and internationally. Thematic communication campaigns will also be developed to meet the needs of the main stakeholders and strengthen the attractiveness and competitiveness of Quebec. AReNA will also play a supporting role with partner organizations in their international canvassing efforts.
Christopher Skeete, Minister for the Economy, Minister responsible for the Fight against Racism and Minister responsible for the Laval region: “With projects like AReNA, we are developing a solid RNA sector in Quebec. By bringing together our resources, we distinguish ourselves as a leader in this promising field. »
Pierre Fitzgibbon, Minister of Economy, Innovation and Energy, Minister responsible for Regional Economic Development and Minister responsible for the Metropolis and the Montreal region: “Quebec is fortunate to be able to count on researchers of great caliber in RNA-based therapies. It is with projects like this that we will continue to stand out internationally in this strategic sector. »
“ Quebec is home to a large community of RNA researchers, highly competitive and attractive, which will contribute to the development of the RNA therapy sector, the training of a qualified next generation and the influence of Quebec. The creation of AReNA, the new Pôle RNA du Québec, will serve as a lever to stimulate research and innovation and accelerate the valorization of discoveries by strengthening links with industry and other key players in our ecosystem. ARN Québec is committed to leveraging the know-how of the scientific community and working closely with other partners serving the RNA therapy sector in Quebec ,” underlined Prof. Barbara Papadopoulou, Director of ARN Québec. .
“ The creation of AReNA represents an important new milestone in the emergence and development of the RNA therapy sector in Quebec. In addition to raising awareness and promoting all of Quebec's know-how in the field of RNA therapies on a national and international scale, this new center will contribute to strengthening the links between academic research and players in the field of life sciences. established in Quebec. These are all new levers that will help Quebec market its innovative RNA technologies on local, national and international markets, including those that initially emerged in our public research centers ,” underlined Jesse Vincent-Herscovici, President and CEO. by Axelys.
Diane Gosselin, CEO of CQDM: “As the biopharmaceutical world enters the era of RNA therapies, it is time to capitalize on Quebec's high-caliber expertise in this field. AReNA mobilizes key players in Quebec and highlights Quebec expertise, resources and businesses, while stimulating the development of a culture, skills, tools and innovations essential to the development of health therapies. tomorrow."
“The influence and development of the sector also requires targeted and effective networking opportunities between the different players. The Events component of AReNA will focus on existing initiatives in the ecosystem, on the creation of specific events as well as on the attraction of international conferences. Our common desire is to promote our capabilities well beyond our province. We look forward to using our expertise in events and mobilizing stakeholders to serve the RNA therapy sector in Quebec. » said Frank Béraud, CEO of Montréal InVivo.
- 30 -
About AReNA:
Founded on the initiative of CQDM in collaboration with ARN Québec, Axelys and Montréal InVivo, AReNA's mission is to unite and promote the strong forces of Quebec in the RNA therapy sector with the aim of making Quebec is a center of attractiveness in this sector on the national and international scene. AReNA also works closely with the main players in the RNA sector in Quebec to amplify its impact. For more information, please visit the website: arenapole.ca
About ARN Québec:
ARN Québec is a strategic RNA research and innovation consortium that brings together nearly 130 university laboratories from 6 universities and affiliated research centers in Quebec. It aims to mobilize and support the scientific community in order to accelerate research and innovation in RNA, stimulate partnerships with the industrial sector and support a government strategy to increase the development of therapeutic, diagnostic and biotechnological applications based on RNA. for sustainable health and environment. ARN Québec brings together an invaluable source of talent and cutting-edge expertise in ARN, trains qualified young people and is a unique showcase of Quebec's advances internationally. For more information, please consult the website: arnquebec.ca
About Axelys:
Axelys is the company for the development and transfer of innovations resulting from public research in Quebec. It contributes to the economic and social prosperity of the province by accelerating the maturation and deployment of inventions, know-how or processes with high potential to turn them into innovations that will have the capacity to improve the world in which we live. . It also contributes to the creation of scientific companies resulting from public research. For more information, please visit the website: axelys.ca
About CQDM:
Biopharma innovation facilitator
CQDM is a non-profit biopharmaceutical research consortium whose mission is to support and facilitate multi-party collaborative R&D aimed at accelerating the translation or transformation of innovative technologies into solutions meeting specific needs. unmet medical needs, while generating significant benefits for the Quebec and Canadian economies. For more information, please visit the website: cqdm.org
About Montréal InVivo:
Montréal InVivo represents the life sciences and health technologies cluster of metropolitan Montreal which is made up of nearly 600 organizations, including more than 150 research centers, 80 subsidiaries of world-class companies and more than 40,000 people working in the sector. Montréal InVivo is a non-profit economic development organization that aims to create an environment conducive to innovation, growth and competitiveness of public and private organizations in the ecosystem. For more information, please visit the website: montreal-invivo.com
Media Contact:
Julia Serafino
Communications and Marketing Coordinator
CQDM
438 543-9498
[email protected]
Anie Perrault
Special Advisor
MERCURE Conseil
514-700-5550, ext. 560
[email protected]